stockportfolio.pro
Medpace Holdings, Inc. P/E Ratio 2015–2025
Medpace Holdings, Inc. (MEDP) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth -9.3%/yr over 10 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 36.76 | +39.7% |
| FY 2024 | 26.30 | -23.8% |
| FY 2023 | 34.52 | +18.3% |
| FY 2022 | 29.18 | -35.5% |
| FY 2021 | 45.25 | +24.8% |
| FY 2020 | 36.25 | +15.1% |
| FY 2019 | 31.48 | +17.2% |
| FY 2018 | 26.87 | -27.4% |
| FY 2017 | 37.00 | -62.0% |
| FY 2016 | 97.49 | — |
| FY 2015 | — | — |
Source: Medpace Holdings, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Medpace Holdings, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeMedpace Holdings, Inc. — frequently asked questions
What is Medpace Holdings, Inc.'s price-to-earnings ratio?
Medpace Holdings, Inc. (MEDP) reported price-to-earnings ratio of 36.76 for fiscal year 2025, per its SEC filings.
How has Medpace Holdings, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2015 and 2025, MEDP's price-to-earnings ratio declined at roughly 9.3% per year (compound annual rate), from 97.49 to 36.76.
Where does this data come from?
Figures are computed from Medpace Holdings, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.